Double sequential immunostaining for cytokeratin 5/6 and AMACR: an alternative approach in evaluating problematic prostatic specimens.
Trpkov
Kiril
K
Bartczak-McKay
Joanna
J
Yilmaz
Asli
A
D000230:Adenocarcinoma / Q000175:diagnosis / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism; D019084:Fluorescent Antibody Technique, Indirect / Q000379:methods*; D006801:Humans; D053555:Keratin-5 / Q000378:metabolism*; D053553:Keratin-6 / Q000378:metabolism*; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D019998:Racemases and Epimerases / Q000378:metabolism*
D014408:Biomarkers, Tumor; D053555:Keratin-5; D053553:Keratin-6; D019998:Racemases and Epimerases; C108352:alpha-methylacyl-CoA racemase